930
Views
13
CrossRef citations to date
0
Altmetric
Hematology

Real-world economic burden of hematopoietic cell transplantation among a large US commercially insured population with hematologic malignancies

, , , , , & show all
Pages 1244-1251 | Received 30 May 2017, Accepted 03 Aug 2017, Published online: 24 Aug 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Tycel Phillips, Kristen Migliaccio-Walle, Kristina S. Yu, Brian Bloudek, Nicholas Liu, Michelle Fanale & John M. Burke. (2023) Estimating long-term outcomes in classic Hodgkin lymphoma: a United States population-based oncology simulation model based on overall survival from the ECHELON-1 trial. Leukemia & Lymphoma 64:5, pages 1017-1025.
Read now

Articles from other publishers (11)

Navneet S. Majhail, Beckley Miller, Rebecca Dean, Rocio Manghani, Heayoung Shin, Smitha Sivaraman & Richard T. Maziarz. (2023) Hospitalization and Healthcare Resource Utilization of Omidubicel-Onlv versus Umbilical Cord Blood Transplantation for Hematologic Malignancies: Secondary Analysis from a Pivotal Phase 3 Clinical Trial. Transplantation and Cellular Therapy 29:12, pages 749.e1-749.e5.
Crossref
Austin R. Waters, Caitlin B. Biddell, Mary Killela, Kimberly A. Kasow, Kristin Page, Stephanie B. Wheeler, Sarah W. Drier, Matthew S. Kelly, Joanna Robles & Lisa P. Spees. (2023) Financial burden and recommended multilevel solutions among caregivers of pediatric hematopoietic stem cell transplant recipients. Pediatric Blood & Cancer 70:12.
Crossref
Ehab L. Atallah, Rodrigo Maegawa, Dominick Latremouille-Viau, Carmine Rossi & Annie Guérin. (2022) Chronic Myeloid Leukemia: Part II—Cost of Care Among Patients in Advanced Phases or Later Lines of Therapy in Chronic Phase in the United States from a Commercial Perspective. Journal of Health Economics and Outcomes Research 9:2.
Crossref
Ehab Atallah, Rodrigo Maegawa, Dominick Latremouille-Viau, Carmine Rossi & Annie Guérin. (2022) Chronic Myeloid Leukemia: Part II—Cost of Care Among Patients in Advanced Phases or Later Lines of Therapy in Chronic Phase in the United States from a Commercial Perspective. Journal of Health Economics and Outcomes Research 9:2, pages 30-36.
Crossref
Gwendolyn van Gorkom, Catharina Van Elssen, Ian Janssen, Siebren Groothuis, Silvia Evers & Gerard Bos. (2022) The impact of donor type on resource utilisation and costs in allogeneic haematopoietic stem cell transplantation in the Netherlands. European Journal of Haematology 108:4, pages 327-335.
Crossref
Machaon Bonafede, Elias Anaissie, Kristin Evans & Robbin Itzler. (2021) Healthcare utilization and cost of cancer-related care prior to allogeneic hematopoietic cell transplantation for hematologic malignancies in the US: a retrospective real-world analysis. BMC Health Services Research 21:1.
Crossref
Lili Xie, Chen Shen, Yaqin Shi & Huiling Li. (2021) Caregiver Burden Among Primary Family Caregivers of Patients Undergoing Hematopoietic Stem Cell Transplantation. Cancer Nursing 44:6, pages E556-E566.
Crossref
Jifang Zhou, Edith A. Nutescu, Jin Han & Gregory S. Calip. (2020) Clinical trajectories, healthcare resource use, and costs of long-term hematopoietic stem cell transplantation survivors: a latent class analysis. Journal of Cancer Survivorship 14:3, pages 294-304.
Crossref
Neil Dunavin, Lih-Wen Mau, Christa L. Meyer, Clint Divine, Al-Ola Abdallah, Susan Leppke, Anita D'Souza, Ellen Denzen, Wael Saber, Linda J. Burns & Siddhartha Ganguly. (2020) Health Care Reimbursement, Service Utilization, and Outcomes among Medicare Beneficiaries with Multiple Myeloma Receiving Autologous Hematopoietic Cell Transplantation in Inpatient and Outpatient Settings. Biology of Blood and Marrow Transplantation 26:4, pages 805-813.
Crossref
Lih-Wen Mau, Christa Meyer, Linda J Burns, Wael Saber, Patricia Steinert, David J Vanness, Jaime M Preussler, Alicia Silver, Susan Leppke, Elizabeth A Murphy & Ellen Denzen. (2019) Reimbursement, Utilization, and 1-Year Survival Post-Allogeneic Transplantation for Medicare Beneficiaries With Acute Myeloid Leukemia. JNCI Cancer Spectrum 3:4.
Crossref
Jifang Zhou, Jin Han, Edith A. Nutescu, Pritesh R. Patel, Karen Sweiss & Gregory S. Calip. (2019) Discontinuation and Nonadherence to Medications for Chronic Conditions after Hematopoietic Cell Transplantation: A 6‐Year Propensity Score–Matched Cohort Study. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 39:1, pages 55-66.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.